Rebecca Barmherzig1, Thilinie Rajapakse2,3. 1. Division of Neurology, Children's Hospital of Philadelphia, Philadelphia, PA, USA. 2. Department of Pediatrics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada. Thilinie.Rajapakse@ahs.ca. 3. Stollery Children's Hospital, Women & Children's Research Institute, Edmonton, AB, Canada. Thilinie.Rajapakse@ahs.ca.
Abstract
PURPOSE OF REVIEW: Headache affects and disables at least 1 billion people worldwide. Patients and providers seek new therapies to relieve headache without the side effects and financial burden of current treatments. This narrative review highlights recent treatment advances in integrative headache medicine: nutraceuticals and behavioral therapies. RECENT FINDINGS: Growing use of complementary and alternative medicine (CAM) therapies for headache (riboflavin, coenzyme Q10, magnesium, vitamin D, melatonin) alongside mainstream treatments is increasing with improving evidence of quality, safety, and tolerability. Increasing interest in medical cannabis is tempered by lack of evidence regarding safety and efficacy. Behavioral therapies including cognitive behavioral therapy (CBT), biofeedback, mindfulness-based stress reduction (MBSR), and acceptance and commitment therapy (ACT) improve patient resiliency and self-efficacy outcomes and reduce disability. The body of evidence for nutraceutical and behavioral CAM interventions for headache continues to grow and improve in quality. Providers and patients should educate themselves regarding CAM therapies as part of integrative headache management. Future studies should examine combinatorial trials of CAM therapies against current standards of headache care.
PURPOSE OF REVIEW: Headache affects and disables at least 1 billion people worldwide. Patients and providers seek new therapies to relieve headache without the side effects and financial burden of current treatments. This narrative review highlights recent treatment advances in integrative headache medicine: nutraceuticals and behavioral therapies. RECENT FINDINGS: Growing use of complementary and alternative medicine (CAM) therapies for headache (riboflavin, coenzyme Q10, magnesium, vitamin D, melatonin) alongside mainstream treatments is increasing with improving evidence of quality, safety, and tolerability. Increasing interest in medical cannabis is tempered by lack of evidence regarding safety and efficacy. Behavioral therapies including cognitive behavioral therapy (CBT), biofeedback, mindfulness-based stress reduction (MBSR), and acceptance and commitment therapy (ACT) improve patient resiliency and self-efficacy outcomes and reduce disability. The body of evidence for nutraceutical and behavioral CAM interventions for headache continues to grow and improve in quality. Providers and patients should educate themselves regarding CAM therapies as part of integrative headache management. Future studies should examine combinatorial trials of CAM therapies against current standards of headache care.
Entities:
Keywords:
Behavioral therapy; Complementary and alternative medicine; Headache; Integrative medicine; Migraine; Nutraceuticals
Authors: Andrew M Blumenfeld; Lisa M Bloudek; Werner J Becker; Dawn C Buse; Sepideh F Varon; Gregory A Maglinte; Teresa K Wilcox; Ariane K Kawata; Richard B Lipton Journal: Headache Date: 2013-03-04 Impact factor: 5.887
Authors: Zsolt Hepp; David W Dodick; Sepideh F Varon; Patrick Gillard; Ryan N Hansen; Emily B Devine Journal: Cephalalgia Date: 2014-08-27 Impact factor: 6.292
Authors: Andrew Messali; Joanna C Sanderson; Andrew M Blumenfeld; Peter J Goadsby; Dawn C Buse; Sepideh F Varon; Michael Stokes; Richard B Lipton Journal: Headache Date: 2016-02-01 Impact factor: 5.887
Authors: Zsolt Hepp; David W Dodick; Sepideh F Varon; Jenny Chia; Nitya Matthew; Patrick Gillard; Ryan N Hansen; Emily Beth Devine Journal: Cephalalgia Date: 2016-11-12 Impact factor: 6.292